Organ Transplant Immunosuppressant Drugs Global Market Report 2024

Description

“Organ Transplant Immunosuppressant Drugs Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on organ transplant immunosuppressant drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for organ transplant immunosuppressant drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The organ transplant immunosuppressant drugs market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Drug Class: Calcineurin Inhibitors; Antiproliferative Agents; mTOR Inhibitor; Steroids; Others Drug Classes
2) By Transplant Type: Heart; Kidney; Liver; Lung; Pancreas; Other Transplant Types
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: Astellas Pharma Inc.; F. Hoffmann-La Roche AG; Novartis AG; Accord Healthcare Limited; GlaxoSmithKline PLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Organ transplant immunosuppressant drugs are crucial medications employed to curb the immune response in transplant recipients, mitigating the risk of rejection against the transplanted organ.

These drugs primarily fall into several classes calcineurin inhibitors, antiproliferative agents, mTOR inhibitors, steroids, and other miscellaneous classes. Calcineurin, an enzyme pivotal in T-cell activation, prompts the immune system to attack transplanted organs. Calcineurin inhibitors serve to prevent such rejection reactions in patients undergoing organ transplantation. These drugs find extensive use in heart, kidney, liver, lung, pancreas, and other organ transplants, and they are typically dispensed through hospital pharmacies, retail outlets, and online pharmacy platforms.

The organ transplant immunosuppressant drugs market research report is one of a series of new reports from The Business Research Company that provides organ transplant immunosuppressant drugs market statistics, including organ transplant immunosuppressant drugs industry global market size, regional shares, competitors with an organ transplant immunosuppressant drugs market share, detailed organ transplant immunosuppressant drugs market segments, market trends and opportunities, and any further data you may need to thrive in the organ transplant immunosuppressant drugs industry. This organ transplant immunosuppressant drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The organ transplant immunosuppressant drugs market size has grown steadily in recent years. It will grow from $5.24 billion in 2023 to $5.42 billion in 2024 at a compound annual growth rate (CAGR) of 3.4%. In the historic period, growth can be credited to various contributing factors. There was a notable increase in transplant procedures, bolstered by advancements in healthcare infrastructure and substantial investments in research and development. The global aging population also played a significant role, alongside heightened awareness regarding the importance and viability of organ transplantation.

The organ transplant immunosuppressant drugs market size is expected to see steady growth in the next few years. It will grow to $6.29 billion in 2028 at a compound annual growth rate (CAGR) of 3.8%. Anticipated growth in the forecast period is expected to result from several key factors. These include the emergence of novel therapies, a noticeable upsurge in organ failure incidences, the advent of personalized medicine, and the influence of global health initiatives, supported by international collaborations.

The organ transplant immunosuppressant drugs market is poised for growth due to the increasing demand for organ transplantation. This life-saving surgical procedure involves replacing damaged organs with healthy ones from donors. Immunosuppressant drugs are vital to prevent organ rejection post-transplantation. Notably, in 2021, the Global Observatory on Donation and Transplantation reported a significant 11.3% annual increase, with 144,302 organ transplants performed. This surge underscores the driving force propelling the organ transplant immunosuppressant drugs market.

The expanding geriatric population is projected to fuel the growth of the organ transplant immunosuppressant drugs market. Immunosuppressants are crucial for elderly transplant recipients, necessitating tailored drug regimens to prevent rejection while mitigating potential adverse effects and drug interactions. By 2030, the World Health Organization estimates that 1 in 6 people worldwide will be aged 60 or older, reaching 1.4 billion, doubling to 2.1 billion by 2050. This demographic shift underscores the market's growth driven by the expanding geriatric populace.

Product innovation emerges as a key trend shaping the organ transplant immunosuppressant drugs market. Major industry players are focused on developing innovative solutions such as combination therapies, enhancing immunosuppression efficacy while reducing side effects. For example, in July 2021, the FDA approved Prograf for use in combination with other immunosuppressants, expanding its application to prevent organ rejection in kidney, liver, or heart transplant recipients. This emphasis on combination therapies aligns with market demand for improved treatment options.

Market leaders in the organ transplant immunosuppressant drugs sector prioritize advanced drug solutions to augment their product portfolios and meet patient needs. Advanced medications aim to modulate the immune system in transplant recipients. For instance, in August 2023, Strides Pharma Science Ltd. secured USFDA approval for Cyclosporine Softgel Capsules USP (Modified), catering to kidney, liver, and heart transplant recipients. This approval reinforces Strides' position in the immunosuppressant market, complementing their existing offerings and enhancing patient care outcomes.

In September 2021, Sanofi S.A., a leading French pharmaceutical and healthcare enterprise, successfully acquired Kadmon Holdings for around $1.9 billion. This strategic move by Sanofi was driven by its goal to amplify its transplant-related portfolio and pipeline. The acquisition primarily aimed to incorporate Kadmon's immunosuppressant drug, Rezurock, recently approved by the US FDA for addressing chronic graft-versus-host disease (cGVHD). Kadmon Holdings Inc., a US-based biopharmaceutical company, specializes in the development and distribution of organ transplant immunosuppressant drugs.

Major companies operating in the organ transplant immunosuppressant drugs market report are Astellas Pharma Inc., F. Hoffmann-La Roche AG, Novartis AG, Accord Healthcare Limited, GlaxoSmithKline PLC, Pfizer Inc., Sanofi S.A., Alsachim a Shimadzu Group Company, Neovii Pharmaceuticals AG, Zydus Lifesciences Limited, Dr. Reddy's Laboratories Ltd., Lupin Limited, Mylan N.V., Strides Pharma Global Pte Ltd., Asahi Kasei Corporation, Bristol-Myers Squibb Company, GSK PLC, Veloxis Pharmaceuticals A/S, Viatris Inc., Janssen Pharmaceuticals Inc., AbbVie Inc., Hansa Biopharma AB, Wockhardt Ltd., Glenmark Pharmaceuticals Ltd., Biocon Ltd., Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd., Cipla Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Intas Pharmaceuticals Limited, Alkem Laboratories Limited, Torrent Pharmaceuticals Limited

North America was the largest region in the organ transplant immunosuppressant drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global organ transplant immunosuppressant drugs market report during the forecast period. The regions covered in the organ transplant immunosuppressant drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the organ transplant immunosuppressant drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The organ transplant immunosuppressant drugs market consists of sales of drugs such asteroid-sparing immunosuppressants, prednisone, antineoplastics, monoclonal antibody drug, and immunosuppressive agents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11976

1. Executive Summary

2. Organ Transplant Immunosuppressant Drugs Market Characteristics

3. Organ Transplant Immunosuppressant Drugs Market Trends And Strategies

4. Organ Transplant Immunosuppressant Drugs Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Organ Transplant Immunosuppressant Drugs Market Size and Growth

5.1. Global Organ Transplant Immunosuppressant Drugs Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Organ Transplant Immunosuppressant Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Organ Transplant Immunosuppressant Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Organ Transplant Immunosuppressant Drugs Market Segmentation

6.1. Global Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Calcineurin Inhibitors
Antiproliferative Agents
mTOR Inhibitor
Steroids
Others Drug Classes
6.2. Global Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Heart
Kidney
Liver
Lung
Pancreas
Other Transplant Types
6.3. Global Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

7. Organ Transplant Immunosuppressant Drugs Market Regional And Country Analysis

7.1. Global Organ Transplant Immunosuppressant Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Organ Transplant Immunosuppressant Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Organ Transplant Immunosuppressant Drugs Market

8.1. Asia-Pacific Organ Transplant Immunosuppressant Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Organ Transplant Immunosuppressant Drugs Market

9.1. China Organ Transplant Immunosuppressant Drugs Market Overview
9.2. China Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Organ Transplant Immunosuppressant Drugs Market

10.1. India Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Organ Transplant Immunosuppressant Drugs Market

11.1. Japan Organ Transplant Immunosuppressant Drugs Market Overview
11.2. Japan Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Organ Transplant Immunosuppressant Drugs Market

12.1. Australia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Organ Transplant Immunosuppressant Drugs Market

13.1. Indonesia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Organ Transplant Immunosuppressant Drugs Market

14.1. South Korea Organ Transplant Immunosuppressant Drugs Market Overview
14.2. South Korea Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Organ Transplant Immunosuppressant Drugs Market

15.1. Western Europe Organ Transplant Immunosuppressant Drugs Market Overview
15.2. Western Europe Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Organ Transplant Immunosuppressant Drugs Market

16.1. UK Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Organ Transplant Immunosuppressant Drugs Market

17.1. Germany Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Organ Transplant Immunosuppressant Drugs Market

18.1. France Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Organ Transplant Immunosuppressant Drugs Market

19.1. Italy Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Organ Transplant Immunosuppressant Drugs Market

20.1. Spain Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Organ Transplant Immunosuppressant Drugs Market

21.1. Eastern Europe Organ Transplant Immunosuppressant Drugs Market Overview
21.2. Eastern Europe Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Organ Transplant Immunosuppressant Drugs Market

22.1. Russia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Organ Transplant Immunosuppressant Drugs Market

23.1. North America Organ Transplant Immunosuppressant Drugs Market Overview
23.2. North America Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Organ Transplant Immunosuppressant Drugs Market

24.1. USA Organ Transplant Immunosuppressant Drugs Market Overview
24.2. USA Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Organ Transplant Immunosuppressant Drugs Market

25.1. Canada Organ Transplant Immunosuppressant Drugs Market Overview
25.2. Canada Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Organ Transplant Immunosuppressant Drugs Market

26.1. South America Organ Transplant Immunosuppressant Drugs Market Overview
26.2. South America Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Organ Transplant Immunosuppressant Drugs Market

27.1. Brazil Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Organ Transplant Immunosuppressant Drugs Market

28.1. Middle East Organ Transplant Immunosuppressant Drugs Market Overview
28.2. Middle East Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Organ Transplant Immunosuppressant Drugs Market

29.1. Africa Organ Transplant Immunosuppressant Drugs Market Overview
29.2. Africa Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Organ Transplant Immunosuppressant Drugs Market Competitive Landscape And Company Profiles

30.1. Organ Transplant Immunosuppressant Drugs Market Competitive Landscape
30.2. Organ Transplant Immunosuppressant Drugs Market Company Profiles
- 30.2.1. Astellas Pharma Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. F. Hoffmann-La Roche AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Novartis AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Accord Healthcare Limited
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. GlaxoSmithKline PLC
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Organ Transplant Immunosuppressant Drugs Market Competitive Benchmarking

32. Global Organ Transplant Immunosuppressant Drugs Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Organ Transplant Immunosuppressant Drugs Market

34. Organ Transplant Immunosuppressant Drugs Market Future Outlook and Potential Analysis

34.1 Organ Transplant Immunosuppressant Drugs Market In 2028 - Countries Offering Most New Opportunities
34.2 Organ Transplant Immunosuppressant Drugs Market In 2028 - Segments Offering Most New Opportunities
34.3 Organ Transplant Immunosuppressant Drugs Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer